董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Jason R. Bernhard | 男 | Independent Director | 60 | 42.20万美元 | 未持股 | 2026-01-20 |
| Michael J. Fucci | 男 | Independent Director | 67 | 16.00万美元 | 未持股 | 2026-01-20 |
| R. David Kelly | -- | Independent Director | -- | 未披露 | 未持股 | 2026-01-20 |
| Patrice A. Harris | -- | Independent Director | -- | 未披露 | 未持股 | 2026-01-20 |
| Vicky B. Gregg | 女 | Independent Director | 71 | 35.70万美元 | 未持股 | 2026-01-20 |
| Debra K. Osteen | 女 | Chief Executive Officer and Director | 71 | 513.14万美元 | 未持股 | 2026-01-20 |
| Wade D. Miquelon | 男 | Independent Director | 61 | 33.58万美元 | 未持股 | 2026-01-20 |
| Reeve B. Waud | 男 | Chairman of the Board | 63 | 60.20万美元 | 未持股 | 2026-01-20 |
| William F. Grieco | 男 | Independent Director | 73 | 51.08万美元 | 未持股 | 2026-01-20 |
| E. Perot Bissell | 男 | Independent Director | 66 | 51.78万美元 | 未持股 | 2026-01-20 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Timothy Sides | 男 | Senior Vice President, Operations Finance | 48 | 未披露 | 未持股 | 2026-01-20 |
| Brian P. Farley | -- | Executive Vice President,General Counsel and Secretary | -- | 未披露 | 未持股 | 2026-01-20 |
| Todd Young | 男 | Chief Financial Officer | 55 | 未披露 | 未持股 | 2026-01-20 |
| Debra K. Osteen | 女 | Chief Executive Officer and Director | 71 | 513.14万美元 | 未持股 | 2026-01-20 |
董事简历
中英对照 | 中文 | 英文- Jason R. Bernhard
-
Jason R.Bernhard是北美金融顾问的首席运营官，北美医疗保健投资银行业务的董事总经理，以及Lazard Ltd投资银行业务的副主席，在那里他服务了20多年。
Jason R. Bernhard is the Chief Operating Officer, Financial Advisory North America; Managing Director, Head of North America Healthcare Investment Banking; and a Vice Chairman of Investment Banking at Lazard Ltd, where he has served for more than 20 years. - Jason R.Bernhard是北美金融顾问的首席运营官，北美医疗保健投资银行业务的董事总经理，以及Lazard Ltd投资银行业务的副主席，在那里他服务了20多年。
- Jason R. Bernhard is the Chief Operating Officer, Financial Advisory North America; Managing Director, Head of North America Healthcare Investment Banking; and a Vice Chairman of Investment Banking at Lazard Ltd, where he has served for more than 20 years.
- Michael J. Fucci
-
Michael J.Fucci，在2020年9月退休之前，他曾担任德勤美国荣誉主席。他此前曾于2015年至2019年担任德勤美国执行主席。2009年至2015年担任德勤咨询首席运营官，自2003年以来担任多个管理职位。Fucci先生还担任德勤美国和德勤全球董事会的成员。在美国德勤（Deloitte U.S.）任职期间，他建立并共同主持了董事会领导论坛（Board Leadership Forum），这是一个由财富500强（Fortune500）董事会主席和首席董事组成的联盟。
Michael J. Fucci,Prior to his retirement in September 2020 Mr. Fucci served as Chairman Emeritus of Deloitte U.S. He previously served as Executive Chairman of Deloitte U.S. from 2015 to 2019 Chief Operating Officer of Deloitte Consulting from 2009 to 2015 and held various management positions since 2003. Mr. Fucci also served as a member on both the Deloitte U.S. and Deloitte Global Boards of Directors. While at Deloitte U.S., he established and co-chaired the Board Leadership Forum, a coalition of Fortune 500 board chairs and lead directors. - Michael J.Fucci，在2020年9月退休之前，他曾担任德勤美国荣誉主席。他此前曾于2015年至2019年担任德勤美国执行主席。2009年至2015年担任德勤咨询首席运营官，自2003年以来担任多个管理职位。Fucci先生还担任德勤美国和德勤全球董事会的成员。在美国德勤（Deloitte U.S.）任职期间，他建立并共同主持了董事会领导论坛（Board Leadership Forum），这是一个由财富500强（Fortune500）董事会主席和首席董事组成的联盟。
- Michael J. Fucci,Prior to his retirement in September 2020 Mr. Fucci served as Chairman Emeritus of Deloitte U.S. He previously served as Executive Chairman of Deloitte U.S. from 2015 to 2019 Chief Operating Officer of Deloitte Consulting from 2009 to 2015 and held various management positions since 2003. Mr. Fucci also served as a member on both the Deloitte U.S. and Deloitte Global Boards of Directors. While at Deloitte U.S., he established and co-chaired the Board Leadership Forum, a coalition of Fortune 500 board chairs and lead directors.
- R. David Kelly
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Patrice A. Harris
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Vicky B. Gregg
-
Vicky B. Gregg，她是Guidon Partners LLC的联合创始人/合伙人。她于2012年退休，担任Blue Cross Blue Shield of Tennessee的首席执行官。在2003年成为首席执行官之前，她曾担任许多其他领导职务，包括总裁和首席运营官。在此之前，她曾在Humana Health Plans担任过一系列高级职位。她曾担任美国国立卫生研究院系统互操作性委员会的成员。她目前担任Acadia Healthcare Company， Inc.， Erlanger Health System和查塔努加电力董事会的董事会成员，以及几家私人公司的董事会成员，包括MyEyeDr。此前，她曾在多个董事会任职，包括2013年至2017年担任上市公司TeamHealth Holdings， Inc.和2011年至2015年担任First Horizon Corporation。她还曾担任美国健康保险计划主席，BlueCross BlueShield Association成员，National Institute for Healthcare Management董事会主席，以及Healthcare Leadership Council成员。
Vicky B. Gregg,is a cofounder/partner of Guidon Partners LLC. She retired as Chief Executive Officer of Blue Cross Blue Shield of Tennessee in 2012. Prior to becoming Chief Executive Officer in 2003, Ms. Gregg served in a number of other leadership roles, including President and Chief Operating Officer. Before that, she held a series of senior roles at Humana Health Plans. Ms. Gregg served as a member of the U.S. National Institutes of Health Commission on Systemic Interoperability. She currently serves on the boards of Acadia Healthcare Company, Inc., Erlanger Health System and the Electric Power Board of Chattanooga, as well as the boards of several private companies, including MyEyeDr. Previously, Ms. Gregg served on several boards, including TeamHealth Holdings, Inc., then a public company, from 2013 to 2017 and First Horizon Corporation from 2011 to 2015. She has also served as Chair of America's Health Insurance Plans, as a member of the BlueCross BlueShield Association, as Chair of the Board of the National Institute for Healthcare Management, and as a member of the Healthcare Leadership Council. - Vicky B. Gregg，她是Guidon Partners LLC的联合创始人/合伙人。她于2012年退休，担任Blue Cross Blue Shield of Tennessee的首席执行官。在2003年成为首席执行官之前，她曾担任许多其他领导职务，包括总裁和首席运营官。在此之前，她曾在Humana Health Plans担任过一系列高级职位。她曾担任美国国立卫生研究院系统互操作性委员会的成员。她目前担任Acadia Healthcare Company， Inc.， Erlanger Health System和查塔努加电力董事会的董事会成员，以及几家私人公司的董事会成员，包括MyEyeDr。此前，她曾在多个董事会任职，包括2013年至2017年担任上市公司TeamHealth Holdings， Inc.和2011年至2015年担任First Horizon Corporation。她还曾担任美国健康保险计划主席，BlueCross BlueShield Association成员，National Institute for Healthcare Management董事会主席，以及Healthcare Leadership Council成员。
- Vicky B. Gregg,is a cofounder/partner of Guidon Partners LLC. She retired as Chief Executive Officer of Blue Cross Blue Shield of Tennessee in 2012. Prior to becoming Chief Executive Officer in 2003, Ms. Gregg served in a number of other leadership roles, including President and Chief Operating Officer. Before that, she held a series of senior roles at Humana Health Plans. Ms. Gregg served as a member of the U.S. National Institutes of Health Commission on Systemic Interoperability. She currently serves on the boards of Acadia Healthcare Company, Inc., Erlanger Health System and the Electric Power Board of Chattanooga, as well as the boards of several private companies, including MyEyeDr. Previously, Ms. Gregg served on several boards, including TeamHealth Holdings, Inc., then a public company, from 2013 to 2017 and First Horizon Corporation from 2011 to 2015. She has also served as Chair of America's Health Insurance Plans, as a member of the BlueCross BlueShield Association, as Chair of the Board of the National Institute for Healthcare Management, and as a member of the Healthcare Leadership Council.
- Debra K. Osteen
-
Debra K. Osteen2005年当选高级副总裁，担任我们行为医疗保健事业部的总裁。2000年，她当选为副总裁；自1984年以来在我们的行为健康保健担任各种职务。
Debra K. Osteen,previously served as Chief Executive Officer of Acadia from December 2018 to March 2022, and as a member of the Board from December 2018 to May 2024. Prior to joining Acadia in December 2018, Ms. Osteen served as Executive Vice President of Universal Health Services, Inc. (NYSE: UHS) and President of UHS's behavioral health division for 19 years. As part of her commitment to the advancement of behavioral healthcare, Ms. Osteen has served as an executive committee member for the National Association for Behavioral Healthcare for more than 20 years, including a two-term seat as president of the board. She also served on the Executive Committee of the National Action Alliance for Suicide Prevention, a public-private partnership advancing the national strategy for suicide prevention. - Debra K. Osteen2005年当选高级副总裁，担任我们行为医疗保健事业部的总裁。2000年，她当选为副总裁；自1984年以来在我们的行为健康保健担任各种职务。
- Debra K. Osteen,previously served as Chief Executive Officer of Acadia from December 2018 to March 2022, and as a member of the Board from December 2018 to May 2024. Prior to joining Acadia in December 2018, Ms. Osteen served as Executive Vice President of Universal Health Services, Inc. (NYSE: UHS) and President of UHS's behavioral health division for 19 years. As part of her commitment to the advancement of behavioral healthcare, Ms. Osteen has served as an executive committee member for the National Association for Behavioral Healthcare for more than 20 years, including a two-term seat as president of the board. She also served on the Executive Committee of the National Action Alliance for Suicide Prevention, a public-private partnership advancing the national strategy for suicide prevention.
- Wade D. Miquelon
-
Wade D. Miquelon，2009年7月开始担任执行副总裁兼财务总监。2012年10月起任国际总裁。2008年7月至2009年7月任高级副总裁兼财务总监。2012年1月起任阿卡迪亚医疗保健公司董事，阿卡迪亚是一家提供住院医疗服务的公司。2012年8月他担任联合博姿公司董事。
Wade D. Miquelon is the President, Chief Executive Officer and a member of the board of directors of JOANN Inc. Nasdaq: JOAN ("Jo-Ann"), the nation's leading fabric and craft specialty retailer. Prior to that, he served as the Chief Financial Officer and Executive Vice President of Jo-Ann. Prior to joining Jo-Ann, he served as Chief Financial Officer, Executive Vice President and President International for Walgreen Co. from June 2008 to August of 2014. From 2006 to 2008 he was Executive Vice President and Chief Financial Officer at Tyson Foods, Inc. Prior to that, Mr. Miquelon served Procter and Gamble in several positions of increasing responsibility. Mr. Miquelon serves on the board of directors of Jo-Ann and the National 4-H Council, and has served on various for profit and non-profit boards including Alliance Boots, the Chicago Lyric Opera and the John G. Shedd Aquarium. - Wade D. Miquelon，2009年7月开始担任执行副总裁兼财务总监。2012年10月起任国际总裁。2008年7月至2009年7月任高级副总裁兼财务总监。2012年1月起任阿卡迪亚医疗保健公司董事，阿卡迪亚是一家提供住院医疗服务的公司。2012年8月他担任联合博姿公司董事。
- Wade D. Miquelon is the President, Chief Executive Officer and a member of the board of directors of JOANN Inc. Nasdaq: JOAN ("Jo-Ann"), the nation's leading fabric and craft specialty retailer. Prior to that, he served as the Chief Financial Officer and Executive Vice President of Jo-Ann. Prior to joining Jo-Ann, he served as Chief Financial Officer, Executive Vice President and President International for Walgreen Co. from June 2008 to August of 2014. From 2006 to 2008 he was Executive Vice President and Chief Financial Officer at Tyson Foods, Inc. Prior to that, Mr. Miquelon served Procter and Gamble in several positions of increasing responsibility. Mr. Miquelon serves on the board of directors of Jo-Ann and the National 4-H Council, and has served on various for profit and non-profit boards including Alliance Boots, the Chicago Lyric Opera and the John G. Shedd Aquarium.
- Reeve B. Waud
-
Reeve B. Waud ，他于1993年创立WCP，担任管理合伙人。他曾担任Golder, Thoma, Cressey, Rauner（私人股本投资集团，总部设在芝加哥）的投资专员。加入GTCR之前，他任职所罗门兄弟公司的金融集团，并担任其风险资本集团的创始成员。目前，他担任控股股东或董事会主席，任职Adreima, The Center for Vein Restoration, ProNerve, Sterling Healthcare Holdings, True Partners Consulting 和 Whitehall Products等私营企业。他任职Northwestern Memorial Foundation（慈善机构，涉及Northwestern Memorial HealthCare的筹款，赠款和管理活动）董事会。他也是一个NMHC财政委员会的成员。他目前担任Green Courte Partners（私人股本房地产投资公司）的顾问。此外，他是芝加哥联邦俱乐部，芝加哥经济俱乐部和芝加哥犯罪委员会的一员。他是圣保罗学校（坐落于新罕布什尔州康科德市）的受托人，以及谢德水族馆的执行委员会成员和审计委员会主席。他被指定为WCP Investors的董事。
Reeve B. Waud founded the Company in 2005 and, most recently, has served as the Chairman of the Board since December 2018. Mr. Waud previously served as the Lead Director of the Board from April 2012 to December 2018. Mr. Waud formed Waud Capital Partners, L.L.C. "WCP" in 1993 and has served as the Managing Partner of WCP since that time. Prior to founding WCP, Mr. Waud was an investment professional at Golder, Thoma, Cressey, Rauner, Inc. ("GTCR"), a private equity investment group based in Chicago, Illinois. Before joining GTCR, Mr. Waud was in the Corporate Finance Group of Salomon Brothers Inc and was a founding member of its Venture Capital Group. He is a member of the Northwestern Memorial HealthCare finance committee, a trustee of the Art Institute of Chicago and serves on the board of directors of The Economic Club of Chicago. In addition, Mr. Waud is the Chairman of the Illinois State Police Merit Board, which has oversight responsibility for the Illinois State Police. - Reeve B. Waud ，他于1993年创立WCP，担任管理合伙人。他曾担任Golder, Thoma, Cressey, Rauner（私人股本投资集团，总部设在芝加哥）的投资专员。加入GTCR之前，他任职所罗门兄弟公司的金融集团，并担任其风险资本集团的创始成员。目前，他担任控股股东或董事会主席，任职Adreima, The Center for Vein Restoration, ProNerve, Sterling Healthcare Holdings, True Partners Consulting 和 Whitehall Products等私营企业。他任职Northwestern Memorial Foundation（慈善机构，涉及Northwestern Memorial HealthCare的筹款，赠款和管理活动）董事会。他也是一个NMHC财政委员会的成员。他目前担任Green Courte Partners（私人股本房地产投资公司）的顾问。此外，他是芝加哥联邦俱乐部，芝加哥经济俱乐部和芝加哥犯罪委员会的一员。他是圣保罗学校（坐落于新罕布什尔州康科德市）的受托人，以及谢德水族馆的执行委员会成员和审计委员会主席。他被指定为WCP Investors的董事。
- Reeve B. Waud founded the Company in 2005 and, most recently, has served as the Chairman of the Board since December 2018. Mr. Waud previously served as the Lead Director of the Board from April 2012 to December 2018. Mr. Waud formed Waud Capital Partners, L.L.C. "WCP" in 1993 and has served as the Managing Partner of WCP since that time. Prior to founding WCP, Mr. Waud was an investment professional at Golder, Thoma, Cressey, Rauner, Inc. ("GTCR"), a private equity investment group based in Chicago, Illinois. Before joining GTCR, Mr. Waud was in the Corporate Finance Group of Salomon Brothers Inc and was a founding member of its Venture Capital Group. He is a member of the Northwestern Memorial HealthCare finance committee, a trustee of the Art Institute of Chicago and serves on the board of directors of The Economic Club of Chicago. In addition, Mr. Waud is the Chairman of the Illinois State Police Merit Board, which has oversight responsibility for the Illinois State Police.
- William F. Grieco
-
William F. Grieco，自2008年以来，他一直担任 Arcadia Strategies（律和商业咨询机构涉及服务医疗、科学和技术公司）的常务董事。从2003年到2008年，他担任美国科学及工程公司（x射线检测技术公司）的高级副总裁兼法律总顾问。从2001年到2002年，他担任IDX Systems公司（一个医疗卫生信息技术公司）的高级副总裁兼法律总顾问。从1995年到1999年，他担任费森尤斯医疗北美（FMCNA）（透析服务和产品的公司）的高级副总裁兼法律总顾问。此前，他担任 Choate, Hall & Stewart（普遍服务的律师事务所）医疗部门的合伙人。自2011年2月以来，他一直担任Echo Therapeutics （NASDAQ：ECTE，医疗设备和专业制药公司）董事会成员 。从1997年2月到2011年11月，他担任董事会成员。他被Bruce A. Shear指定为总监。
William F. Grieco,Since March 2018 Mr. Grieco has served as Vice President and Chief Compliance Officer of NX Development Corporation, the U.S. life sciences affiliate of Tokyo-based SBI Holdings, Inc. Also, since 2008 Mr. Grieco has served as the Managing Director of Arcadia Strategies, LLC, a legal and business consulting organization servicing healthcare, science and technology companies. From 2003 to 2008 he served as Senior Vice President and General Counsel of American Science and Engineering, Inc., an x-ray inspection technology company. From 2001 to 2002 he served as Senior Vice President and General Counsel of IDX Systems Corporation, a healthcare information technology company. Previously, from 1995 to 1999 he was Senior Vice President and General Counsel for Fresenius Medical Care North America, a dialysis service and products company. Prior to that, Mr. Grieco was a partner in the Healthcare Department at Choate, Hall & Stewart, a general service law firm. Mr. Grieco previously served on the board of directors of PHC, Inc. "PHC". - William F. Grieco，自2008年以来，他一直担任 Arcadia Strategies（律和商业咨询机构涉及服务医疗、科学和技术公司）的常务董事。从2003年到2008年，他担任美国科学及工程公司（x射线检测技术公司）的高级副总裁兼法律总顾问。从2001年到2002年，他担任IDX Systems公司（一个医疗卫生信息技术公司）的高级副总裁兼法律总顾问。从1995年到1999年，他担任费森尤斯医疗北美（FMCNA）（透析服务和产品的公司）的高级副总裁兼法律总顾问。此前，他担任 Choate, Hall & Stewart（普遍服务的律师事务所）医疗部门的合伙人。自2011年2月以来，他一直担任Echo Therapeutics （NASDAQ：ECTE，医疗设备和专业制药公司）董事会成员 。从1997年2月到2011年11月，他担任董事会成员。他被Bruce A. Shear指定为总监。
- William F. Grieco,Since March 2018 Mr. Grieco has served as Vice President and Chief Compliance Officer of NX Development Corporation, the U.S. life sciences affiliate of Tokyo-based SBI Holdings, Inc. Also, since 2008 Mr. Grieco has served as the Managing Director of Arcadia Strategies, LLC, a legal and business consulting organization servicing healthcare, science and technology companies. From 2003 to 2008 he served as Senior Vice President and General Counsel of American Science and Engineering, Inc., an x-ray inspection technology company. From 2001 to 2002 he served as Senior Vice President and General Counsel of IDX Systems Corporation, a healthcare information technology company. Previously, from 1995 to 1999 he was Senior Vice President and General Counsel for Fresenius Medical Care North America, a dialysis service and products company. Prior to that, Mr. Grieco was a partner in the Healthcare Department at Choate, Hall & Stewart, a general service law firm. Mr. Grieco previously served on the board of directors of PHC, Inc. "PHC".
- E. Perot Bissell
-
E. Perot Bissell，自2016年以来，Bissell先生一直是Egis Capital Partners，LLC的管理合伙人，该公司是一家投资于安全和保护行业的私募股权公司。Bissell先生曾于2013年至2015年担任能源物流发展公司Next Generation Energy Logistics，LLC的董事长兼首席执行官。在此之前，Bissell先生曾在2012年9月至2013年7月期间担任钻井和勘探支持服务提供商Pilot Logistics Services的副主席。2006年至2012年，他担任独立能源物流公司Maxum Petroleum，Inc.的首席执行官。在此之前，Bissell先生是商业银行和私募股权公司Northwest Capital Appreciation，Inc.的合伙人，在此之前，是专业金融公司SLP Capital的联席管理合伙人兼首席财务官。Bissell先生还担任Mission Critical Partners，LLC和ClearObject，Inc.的董事会成员，并曾在多个慈善委员会任职。
E. Perot Bissell,Since 2016 Mr. Bissell has been a Managing Partner of Egis Capital Partners, LLC, a private equity firm that invests in the security and protection industries. Mr. Bissell served as the Chairman and Chief Executive Officer of Next Generation Energy Logistics, LLC, an energy logistics development company, from 2013 to 2015. Before that, Mr. Bissell served as the Vice Chairman of Pilot Logistics Services, a provider of drilling and exploration support services, from September 2012 until July 2013. From 2006 to 2012 he served as Chief Executive Officer for Maxum Petroleum, Inc., an independent energy logistics company. Prior to that, Mr. Bissell was a Partner of Northwest Capital Appreciation, Inc., a merchant banking and private equity firm, and before that, the Co-Managing Partner and Chief Financial Officer of SLP Capital, a specialty finance company. Mr. Bissell also serves on the board of directors of Mission Critical Partners, LLC and ClearObject, Inc. and has served on a number of charitable boards. - E. Perot Bissell，自2016年以来，Bissell先生一直是Egis Capital Partners，LLC的管理合伙人，该公司是一家投资于安全和保护行业的私募股权公司。Bissell先生曾于2013年至2015年担任能源物流发展公司Next Generation Energy Logistics，LLC的董事长兼首席执行官。在此之前，Bissell先生曾在2012年9月至2013年7月期间担任钻井和勘探支持服务提供商Pilot Logistics Services的副主席。2006年至2012年，他担任独立能源物流公司Maxum Petroleum，Inc.的首席执行官。在此之前，Bissell先生是商业银行和私募股权公司Northwest Capital Appreciation，Inc.的合伙人，在此之前，是专业金融公司SLP Capital的联席管理合伙人兼首席财务官。Bissell先生还担任Mission Critical Partners，LLC和ClearObject，Inc.的董事会成员，并曾在多个慈善委员会任职。
- E. Perot Bissell,Since 2016 Mr. Bissell has been a Managing Partner of Egis Capital Partners, LLC, a private equity firm that invests in the security and protection industries. Mr. Bissell served as the Chairman and Chief Executive Officer of Next Generation Energy Logistics, LLC, an energy logistics development company, from 2013 to 2015. Before that, Mr. Bissell served as the Vice Chairman of Pilot Logistics Services, a provider of drilling and exploration support services, from September 2012 until July 2013. From 2006 to 2012 he served as Chief Executive Officer for Maxum Petroleum, Inc., an independent energy logistics company. Prior to that, Mr. Bissell was a Partner of Northwest Capital Appreciation, Inc., a merchant banking and private equity firm, and before that, the Co-Managing Partner and Chief Financial Officer of SLP Capital, a specialty finance company. Mr. Bissell also serves on the board of directors of Mission Critical Partners, LLC and ClearObject, Inc. and has served on a number of charitable boards.
高管简历
中英对照 | 中文 | 英文- Timothy Sides
Timothy Sides，自2020年2月起受雇于公司，最近担任运营财务高级副总裁。在此之前，Sides先生担任运营集团首席财务官的职务。在加入公司之前，Sides先生于2013年11月至2020年2月期间受雇于环球保健服务公司担任各种财务职务。
Timothy Sides,has been employed by the Company since February 2020, most recently as Senior Vice President, Operations Finance. Prior to that, Mr. Sides served in the role of Operations Group Chief Financial Officer. Prior to joining the Company, Mr. Sides was employed in various financial roles at Universal Health Services, Inc. from November 2013 to February 2020.- Timothy Sides，自2020年2月起受雇于公司，最近担任运营财务高级副总裁。在此之前，Sides先生担任运营集团首席财务官的职务。在加入公司之前，Sides先生于2013年11月至2020年2月期间受雇于环球保健服务公司担任各种财务职务。
- Timothy Sides,has been employed by the Company since February 2020, most recently as Senior Vice President, Operations Finance. Prior to that, Mr. Sides served in the role of Operations Group Chief Financial Officer. Prior to joining the Company, Mr. Sides was employed in various financial roles at Universal Health Services, Inc. from November 2013 to February 2020.
- Brian P. Farley
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Todd Young
Todd Young，加盟公司之前任职于Elanco Animal Health（“Elanco”），自2018年11月起担任执行副总裁兼首席财务官。在加入Elanco之前，他于2016年8月至2018年10月在生物制药公司ACADIA Pharmaceuticals Inc.担任执行副总裁兼首席财务官，负责监督其财务职能以及信息技术和设施。他在格林内尔学院获得经济学学士学位，在密歇根大学法学院获得法学学位。
Todd Young,joins the Company from Elanco Animal Health ("Elanco"), where he served as Executive Vice President and Chief Financial Officer since November 2018. Prior to joining Elanco, he served as Executive Vice President and Chief Financial Officer at ACADIA Pharmaceuticals Inc., a biopharmaceutical company, from August 2016 to October 2018, where he oversaw their financial functions as well as information technology and facilities. He earned a bachelor's degree in economics from Grinnell College and a law degree from the University of Michigan School of Law.- Todd Young，加盟公司之前任职于Elanco Animal Health（“Elanco”），自2018年11月起担任执行副总裁兼首席财务官。在加入Elanco之前，他于2016年8月至2018年10月在生物制药公司ACADIA Pharmaceuticals Inc.担任执行副总裁兼首席财务官，负责监督其财务职能以及信息技术和设施。他在格林内尔学院获得经济学学士学位，在密歇根大学法学院获得法学学位。
- Todd Young,joins the Company from Elanco Animal Health ("Elanco"), where he served as Executive Vice President and Chief Financial Officer since November 2018. Prior to joining Elanco, he served as Executive Vice President and Chief Financial Officer at ACADIA Pharmaceuticals Inc., a biopharmaceutical company, from August 2016 to October 2018, where he oversaw their financial functions as well as information technology and facilities. He earned a bachelor's degree in economics from Grinnell College and a law degree from the University of Michigan School of Law.
- Debra K. Osteen
Debra K. Osteen2005年当选高级副总裁，担任我们行为医疗保健事业部的总裁。2000年，她当选为副总裁；自1984年以来在我们的行为健康保健担任各种职务。
Debra K. Osteen,previously served as Chief Executive Officer of Acadia from December 2018 to March 2022, and as a member of the Board from December 2018 to May 2024. Prior to joining Acadia in December 2018, Ms. Osteen served as Executive Vice President of Universal Health Services, Inc. (NYSE: UHS) and President of UHS's behavioral health division for 19 years. As part of her commitment to the advancement of behavioral healthcare, Ms. Osteen has served as an executive committee member for the National Association for Behavioral Healthcare for more than 20 years, including a two-term seat as president of the board. She also served on the Executive Committee of the National Action Alliance for Suicide Prevention, a public-private partnership advancing the national strategy for suicide prevention.- Debra K. Osteen2005年当选高级副总裁，担任我们行为医疗保健事业部的总裁。2000年，她当选为副总裁；自1984年以来在我们的行为健康保健担任各种职务。
- Debra K. Osteen,previously served as Chief Executive Officer of Acadia from December 2018 to March 2022, and as a member of the Board from December 2018 to May 2024. Prior to joining Acadia in December 2018, Ms. Osteen served as Executive Vice President of Universal Health Services, Inc. (NYSE: UHS) and President of UHS's behavioral health division for 19 years. As part of her commitment to the advancement of behavioral healthcare, Ms. Osteen has served as an executive committee member for the National Association for Behavioral Healthcare for more than 20 years, including a two-term seat as president of the board. She also served on the Executive Committee of the National Action Alliance for Suicide Prevention, a public-private partnership advancing the national strategy for suicide prevention.